English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
15 天
百济神州2024年业绩解析:创新药驱动高增长,全球化战略重塑竞争格局
全球肿瘤治疗市场规模持续扩容,据Evaluate Pharma预测,到2025年全球抗肿瘤药物市场规模将突破2600亿美元。与此同时,中国创新药企通过差异化研发和国际化布局,逐步打破跨国药企的垄断格局。百济神州作为“中美双报、全球同步开发”的先行者,其核心产品百悦泽®(泽布替尼)、百泽安®(替雷利珠单抗)的海外商业化成功,标志着中国创新药企已具备与国际巨头同台竞技的能力。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
ISR conducts strikes in Gaza
Expanding free tuition
H7N9 bird flu outbreak
'Get Together' singer dies
Stuck astronauts depart ISS
Acquires AI video startup
Trump revokes protection
Delta plane wing hits runway
Tapped as top bank cop
Bryan Bedford to lead FAA
Lunar lander goes silent
Ordered to pay $54K+
Morgan gets sick at MSG
JFK files to be released
DC drops Jan. 6 lawsuit
Lebanon-Syria ceasefire
Judge demands answers
Halts care for trans veterans
Judge cancels hearing
Honduras plane crash
Producer files for bankruptcy
Visits White House
DOGE gains access to USIP?
WH says US won't return
Ex-Texas pastor surrenders
US retail sales rebound
Texas midwife arrested
iHeartRadio Music Awards
Worker stole $1.6 million
Peru declares emergency
反馈